Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17305859 | 0.81 | ALDH1A1 (0.45) | ALDH1A1CYP1A2HPGDLMNACYP3A4 | |
| SCHEMBL19106512 | 0.78 | TGFBR1 (0.33) | ALDH1A1CYP1A2THRBHPGDHSD17B10 | |
| SCHEMBL18853714 | 0.76 | MAPT (0.35) | ALDH1A1CYP1A2HPGDHSD17B10LMNA | |
| SCHEMBL18553237 | 0.76 | RORB (0.40) | ALDH1A1HPGDLMNAMAPT | |
| SCHEMBL2534139 | 0.76 | LIMK1 (0.44) | MAPT | |
| SCHEMBL18853655 | 0.75 | CYP1B1 (0.40) | ALDH1A1CYP1A2HSD17B10LMNACYP3A4 | |
| SCHEMBL22006354 | 0.75 | PSMB8 (0.39) | ALDH1A1CYP1A2HPGDLMNAMAPT | |
| SCHEMBL18553550 | 0.74 | TYMS (0.41) | ALDH1A1CYP1A2THRBHPGDHSD17B10 | |
| SCHEMBL22006582 | 0.70 | PRKCI (0.43) | ALDH1A1HPGDLMNAMAPTMAPK1 | |
| SCHEMBL18852786 | 0.70 | MAPT (0.37) | ALDH1A1CYP1A2THRBHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10680190-B2 | Organic compound, organic optoelectronic element, and display device | SAMSUNG SDI CO., LTD. (KR) | 2020-06-09 | — | — | US | disclosed |
| US-20170141331-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO.,LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170141331-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO.,LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170141331-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | OCIAD1, OXER1, OCIAD2 | ALDH1A1 69/4885CYP1A2 220/4885THRB 3209/4885 |
| US-10680190-B2 | Organic compound, organic optoelectronic element, and display device | OCIAD1, OXER1, OCIAD2 | ALDH1A1 69/4885CYP1A2 220/4885THRB 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.